Pharmaceutical formulations comprising 1-(beta-D-glucopyranosyl)-2-thienylmethylbenzene derivatives as inhibitors of SGLT

• 收藏
• 分享

专利权人:

Janssen Pharmaceutica NV

发明人:

Wang, Wenhua,Outwin, Todd,Joseph, Thomas C.

申请号：

AU2015207823

公开号：

AU2015207823A1

申请日:

2015.07.28

申请国别(地区):

AU

年份:

2015

代理人:

摘要：

#$%^&*AU2015207823A120150820.pdf#####ABSTRACT The present invention relates to formulations including compounds of Formula (1), (Formula (1)) or prodrug, or a pharmaceutically acceptable salt thereof. [FIG 1]1/2 a:T FIG. 1A 10000 9000- o 5mg/mL Nanosuspension o 8000- o 4x25mg tablets E 7000- A 100mg tablet 6000-c_ 50004000 o 30000E 2000 1000 0 80 48 1216 20 24 28 32 36 40 44 48 Time (h) FIG. 1B So100000 o 5mg/mL Nanosuspension o 4x25mg tablets A 100mg tablet 0 u 10000co E 100o 10 .. 0 4 8 12 16 20 24 28 32 36 40444 Time (h)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/